Program overview
Context
Indication: Esophagus Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: SCRI Development Innovations,
Oxaliplatin is flagged as results not found signal because public records show public results not found after completion, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Esophagus Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: SCRI Development Innovations,
Registry: 0/5
Timeline: 1/5
Recruitment burden: 2/5
Results availability: 3/5
Program risk: 3/5
https://clinicaltrials.gov/study/NCT00193128 | https://clinicaltrials.gov/study/NCT01442649
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT00193128 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |
| NCT01442649 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | few_sites_large_trial_signal | strict_eligibility_signal |